PubMed Health⌕ Search

PubMed · 7761570

[The difference between ill persons and patients].

Abstract

Knowledge in psychosomatic medicine is based on clinical experience or on the study of "psychosomatically ill persons", who undergo treatment because of their illness, that is to say on patients. Quite commonly we draw conclusions about an entire population of persons with a specific disorder, or we consider a finding as the correlate of the disorder itself. Several considerations prove this type of generalization wrong, and may lead to false conclusions: for example epidemiological data obtained from rates of medical utilization, the comparison of ill persons and patients suffering from functional gastrointestinal disorders, or a survey of literature about the significance of illness behavior and psychological factors in the demand for medical care. The consequences effect not only the interpretation of empirical results, and the selection of sample survey, but also send a call for fieldstudies on the relevant disorders.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Herschbach. [The difference between ill persons and patients].. https://pubmed.ncbi.nlm.nih.gov/7761570/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Symptoms involving the gastrointestinal tract].

Symptoms involving the gastrointestinal tract are very common in patients who require palliative treatment. They can be caused by the patient's underlying (malignant) disease or by the treatment of this disease. Nausea and vomiting as well as constipation are of the utmost importance in this context due both to their frequency as well as their complex consequences. A careful evaluation of the patient's history combined with a few diagnostic procedures will help to provide a treatment which is orientated on pathophysiology.

Gastrointestinal Diseases↗

Serotonergic receptors in therapeutic approaches to gastrointestinal disorders.

Most of the cloned serotonin (5-HT) receptor subtypes are present on enteric neurons that control gastrointestinal function. Because of the wide distribution of 5-HT receptor subtypes in the gut, the precise actions of currently marketed drugs are unclear. Furthermore, efficacy of these drugs varies between individuals. Two recent advances provide important potential explanations for this phenomenon: polymorphisms have recently been discovered in the gene for the key enzyme in neural 5-HT production, and physiologically relevant 5-HT(4) receptor splice variants have been shown to be differentially located across intestinal regions. Functional 5-HT(7) receptors have recently been demonstrated in the gut and, together with the 5-HT(1A) receptor, offer new therapeutic options. In addition, recently suggested identities for the elusive 5-HT(1P) receptor could result in other, more effective therapeutic targets.

Gastrointestinal Diseases↗